PureTech Health (PRTC) Invested Capital (2019 - 2025)
PureTech Health (PRTC) has disclosed Invested Capital for 6 consecutive years, with $312.1 million as the latest value for Q4 2025.
- For Q4 2025, Invested Capital changed N/A year-over-year to $312.1 million; the TTM value through Dec 2025 reached $312.1 million, changed N/A, while the annual FY2025 figure was $312.1 million, N/A changed from the prior year.
- Invested Capital hit $312.1 million in Q4 2025 for PureTech Health, down from $464.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $645.3 million in Q4 2022 and bottomed at $312.1 million in Q4 2025.
- Average Invested Capital over 4 years is $507.5 million, with a median of $536.3 million recorded in 2021.
- Year-over-year, Invested Capital rose 6.03% in 2022 and then dropped 28.09% in 2023.
- PureTech Health's Invested Capital stood at $608.6 million in 2021, then increased by 6.03% to $645.3 million in 2022, then fell by 28.09% to $464.1 million in 2023, then plummeted by 32.75% to $312.1 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods came in at $312.1 million, $464.1 million, and $645.3 million for Q4 2025, Q4 2023, and Q4 2022 respectively.